Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants.
Hum Vaccin Immunother
; 17(4): 1162-1172, 2021 04 03.
Article
in En
| MEDLINE
| ID: mdl-32966176
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumococcal Infections
/
Pneumococcal Vaccines
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Child
/
Humans
/
Infant
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United States